We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Oncimmune Holdings Plc | ONC | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.05 | -0.48% | 10.45 | 16:35:23 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 10.45 | 10.50 |
| Industry Sector |
|---|
| HEALTH CARE EQUIPMENT & SERVICES |
| Top Posts |
|---|
Posted at 21/5/2024 18:03 by jaknife The interim numbers are absolutely awful, this looks hopelessly uninvestable!P&L * Revenues are trivial at just £1.2m, businesses this small simply shouldn't be listed! * Gross profit down materially as gross margins drop from 69% to just 38% * Significant admin expenses and finance costs push the P&L into a £1.1m loss! Balance sheet * Net equity is negative at -£1.3m * Tangible net equity is -£3.3m! * There's £5.2m of debt! Just £0.9m of cash. Cash Flow * Poor, they burnt £2.2m in H1 alone and obviously need to raise cash They need to do a recap raise to restore the balance sheet but why bother? It's impossible to justify the current market cap of £18.5m. JakNife |
Posted at 12/10/2023 08:19 by brummy_git Encouraging new developments from IPR rich life science firm Oncimmune.All the details here. |
Posted at 31/5/2023 11:15 by eva_1989 I dont know what Trek from LSE smoking but i badly need same ;)He thought to pump before open so that he can sell to others... Hi R00st3R, I think todays interims answer your questions. All good at ONC. Well actually very good! Should be a cracking day today! Pity some of the revs got delayed but there is a line of sight and perhaps most importantly a change in sentiment. Wish I could buy more at this price! Usual caveats Trek |
Posted at 31/5/2023 09:33 by brummy_git H1'23 results out today from Oncimmune. All the details here. |
Posted at 22/5/2023 09:26 by brummy_git Very positive M&A and contract news from global immunodiagnostics group Oncimmune today.All the details here. |
Posted at 27/2/2023 07:13 by brummy_git Final results (y/e Aug'22) out today from global immunodiagnostics firm, OncimmuneAll the details here. |
Posted at 17/2/2023 08:56 by brummy_git Terrific news today from Oncimmune, who is partnering with with Siemens Healthineers to improve the assessment of indeterminate pulmonary nodules.All the details here. |
Posted at 20/12/2022 07:22 by brummy_git More encouraging contract wins for leading immunodiagnostics firm, Oncimmune.All the news and investor commentary here. www.linkedin.com/pos |
Posted at 14/12/2022 15:33 by brummy_git Leading immunodiagnostics firm Oncimmune successfully competes a £2.1m top up fund raise. All the details & commentary here.www.linkedin.com/pos |
Posted at 26/11/2022 07:18 by brummy_git There are 2 golden rules when investing in nascent healthcare stocks.Find out here what they are & potentially how to profit from these secular tailwinds. www.linkedin.com/pos |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
